Tykerb Lapatinib 250mg Tablets, For Hospital, Packaging Type : Box

Tykerb is approved to treat HER2+ breast cancer that’s:

• Advanced or metastatic* and has been treated before with anthracyclines, taxanes, and trastuzumab. For this purpose, Tykerb can be used in both females‡ and males‡, and it’s taken with the chemotherapy drug capecitabine (Xeloda).†
• Hormone-receptor-positive (HR+) and metastatic. For this purpose, Tykerb is taken with letrozole (Femara) by females who’ve gone through menopause, if hormone therapy is recommended as part of their treatment plan.

Tykerb comes as a tablet that you take by mouth. It belongs to a class of medications called tyrosine kinase inhibitors (TKIs). A medication class is a group of medications that work in a similar way.

Tykerb contains the active drug lapatinib.

* Metastatic cancer has spread to other parts of the body, such as the bones.
† Before a person is treated with Tykerb and capecitabine, their cancer needs to have progressed while being treated with trastuzumab.

‡ Sex and gender exist on spectrums. Use of the terms “male” and “female” in this article refers to sex assigned at birth

We are engaged in supplying and exporting Lapatinib Tablet. The offered injection is highly regarded by oncologists for being effective in treating cancer.We are offering a wide range of Lapatinib Tablet which is known for their quick recovery effects.

Features:

• Given intravenouslyAvailable in proper packagingLong shelf life